28139296|t|Lignans from the fruits of Schisandra chinensis (Turcz.) Baill inhibit proprotein convertase subtilisin/kexin type 9 expression
28139296|a|Bioactivity-guided fractionation of the fruits of Schisandra chinensis, using the proprotein convertase subtilisin-kexin type 9 (PCSK9) mRNA expression screening assay, led to isolation of two previously unknown lignans, 14-tigloylschinlignan D and rel-(7R, 8R, 7'R, 8'R)-manglisin E, along with 28 known compounds. All structures were established by NMR spectroscopic data as well as CD and MS analysis. All isolates were tested for their inhibitory activities on the mRNA expression of PCSK9. Of the tested compounds, four of the compounds rel-(7R, 8R, 7'R, 8'R)-manglisin E, (-)-schisandrin C, schinlignan D, and (+)-schisandrol B potently inhibited PCSK9 mRNA expression with IC50 values of 3.15, 3.85, 0.36, and 1.10 Î¼M, respectively. Furthermore, schinlignan D and (+)-schisandrol B were found to suppress PCSK9 protein expressions and schinlignan D deemed to increase low density lipoprotein receptor expression.
28139296	0	7	Lignans	T109	C0064971
28139296	17	23	fruits	T168	C0016767
28139296	27	62	Schisandra chinensis (Turcz.) Baill	T002	C0696946
28139296	63	70	inhibit	T052	C3463820
28139296	71	116	proprotein convertase subtilisin/kexin type 9	T028	C1426592
28139296	117	127	expression	T045	C0017262
28139296	128	160	Bioactivity-guided fractionation	T059	C0016640
28139296	168	174	fruits	T168	C0016767
28139296	178	198	Schisandra chinensis	T002	C0696946
28139296	210	255	proprotein convertase subtilisin-kexin type 9	T028	C1426592
28139296	257	262	PCSK9	T028	C1426592
28139296	264	279	mRNA expression	T045	C1515670
28139296	280	295	screening assay	T059	C1510438
28139296	304	313	isolation	T169	C0205409
28139296	317	320	two	T081	C0205448
28139296	321	339	previously unknown	T080	C0439673
28139296	340	347	lignans	T109	C0064971
28139296	349	372	14-tigloylschinlignan D	T109	C0064971
28139296	377	411	rel-(7R, 8R, 7'R, 8'R)-manglisin E	T109	C0064971
28139296	448	458	structures	T170	C0220807
28139296	464	475	established	T080	C0443211
28139296	479	496	NMR spectroscopic	T060	C0877853
28139296	497	501	data	T078	C1511726
28139296	513	515	CD	T059	C0008813
28139296	520	522	MS	T059	C0037813
28139296	523	531	analysis	T062	C0936012
28139296	551	557	tested	T169	C0039593
28139296	568	578	inhibitory	T052	C3463820
28139296	579	589	activities	T052	C0441655
28139296	597	612	mRNA expression	T045	C1515670
28139296	616	621	PCSK9	T028	C1426592
28139296	630	636	tested	T169	C0039593
28139296	648	652	four	T081	C0205450
28139296	670	704	rel-(7R, 8R, 7'R, 8'R)-manglisin E	T109	C0064971
28139296	706	723	(-)-schisandrin C	T109,T121	C0074176
28139296	725	738	schinlignan D	T109	C0064971
28139296	744	761	(+)-schisandrol B	T109,T121	C0074177
28139296	771	780	inhibited	T080	C0311403
28139296	781	786	PCSK9	T028	C1426592
28139296	787	802	mRNA expression	T045	C1515670
28139296	808	812	IC50	T081	C0600495
28139296	899	916	(+)-schisandrol B	T109,T121	C0074177
28139296	931	939	suppress	T169	C1260953
28139296	940	945	PCSK9	T116,T126	C4255394
28139296	946	965	protein expressions	T045	C1171362
28139296	970	983	schinlignan D	T109	C0064971
28139296	1003	1035	low density lipoprotein receptor	T116,T192	C0034821
28139296	1036	1046	expression	T045	C0597360